Innovative Cell Technologies Fujifilm Cellular Dynamics specializes in developing high-purity, reproducible iPSC-derived human cells that support drug discovery, toxicity testing, and regenerative medicine, creating opportunities to promote advanced cell-based assay and therapy solutions.
Growth through Strategic Alliances The company's recent partnerships and alliances with entities like Neuroservices-Alliance and Opsis Therapeutics indicate a strategic focus on expanding CNS and ocular disease therapies, offering potential sales channels for related biotech products and services.
Facility Investment and Manufacturing With a substantial $21M investment in a cGMP-compliant production facility, Fujifilm Cellular Dynamics is positioned to scale manufacturing of iPSC-derived products, opening sales opportunities in biomanufacturing, CDMO services, and regenerative treatment pipelines.
Pipeline of Cell Therapies The company's focus on developing allogeneic iPSC-based therapies for ocular diseases and collaborations with BlueRock Therapeutics highlight a promising market segment for off-the-shelf cell therapies, providing avenues for targeted product sales and clinical development solutions.
Market Presence and Revenue Generating an estimated revenue between $50M and $100M and maintaining innovative leadership positions, Fujifilm Cellular Dynamics offers a substantial client base for advanced biotech supplies, research reagents, and therapeutic development tools.
$1B$10B
$10B
$1B$10B
$1M$10M
$10B
$500M$1B
$1B$10BFUJIFILM Cellular Dynamics, Inc uses 8 technology products and services including Google Ads, Hotjar, Linkedin Insight Tag, and more. Explore FUJIFILM Cellular Dynamics, Inc's tech stack below.
| FUJIFILM Cellular Dynamics, Inc Email Formats | Percentage |
| FLast@cellulardynamics.com | 94% |
| First.Last@cellulardynamics.com | 4% |
| Last@cellulardynamics.com | 1% |
| F.Last@cellulardynamics.com | 1% |
| First_Last@fujifilmcdi.com | 100% |
Biotechnology ResearchWisconsin, United States51-200 Employees
Fujifilm Cellular Dynamics, Inc. develops and manufactures biologically relevant human cells derived from induced pluripotent stem (iPS) cells. Our iCell® and donor-specific MyCell® Products are highly pure, highly reproducible, and available in industrial quantity to enable drug discovery, toxicity testing, stem cell banking, and cell therapy development.
Company Overview
Media & News
Funding & FinancialsFUJIFILM Cellular Dynamics, Inc's revenue is estimated to be in the range of $50M$100M
Funding & FinancialsFUJIFILM Cellular Dynamics, Inc's revenue is estimated to be in the range of $50M$100M
1-888-653-2347 
support@leadiq.com